Memorial Sloan-Kettering Cancer Center

10% Owner

1 company

Memorial Sloan-Kettering Cancer Center is a 10% Owner at Actinium Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 73 sells.

Estimated insider holdings value: $6.3M based on current market prices.

Holdings by Company

ATNMAug 31, 2016

Current Shares4.81M

Value$6.31M

Net Activity-992,826

Bought: 0Sold: 992.8K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
Aug 31, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	192,927	$1.83	$352,372.39	-0.3%
Aug 29, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	50,000	$1.71	$85,495.02	-0.3%
Aug 16, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	9,468	$1.72	$16,286.96	-
Jul 12, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	3,100	$1.80	$5,581.00	-
Jul 11, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	21,990	$1.80	$39,582.00	-0.2%
Jul 6, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	20,840	$1.81	$37,762.20	-0.1%
Jul 1, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	148,100	$1.81	$268,436.73	-0.1%
Jun 15, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	33,619	$1.90	$63,876.10	-0.6%
Jun 2, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	17,790	$2.01	$35,715.80	-0.2%
Jun 1, 2016	ATNM Actinium Pharmaceuticals, Inc.	10% Owner	Sell	169,450	$1.97	$333,384.51	-0.2%